Menu
Not yet recruiting NCT07519707

Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

No phase Interventional Diabetic Retinopathy (DR) Macular Edema (ME)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Animated Videos.
Who it may be relevant to
Registry conditions: Diabetic Retinopathy (DR), Macular Edema (ME). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Addressing Low Patient Follow-up Rates Among Patients With Diabetes in the Eye Clinic at Zuckerberg San Francisco General Hospital and Trauma Center

Overview

The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.

Detailed description

Health literacy is a prevalent issue at Zuckerberg San Francisco General Hospital, particularly at the eye clinic where understanding of diagnoses and treatment plans largely affect vision outcomes. This study will determine whether video-based explanations, created in both English and Spanish, of diabetic retinopathy can improve knowledge concordance and follow up rates among patients in the eye clinic. Knowledge concordance and patient satisfaction will be assessed through digital surveys in Qualtrics.

Interventions

  • Behavioral Animated Videos
    Animated videos (in English and Spanish) that describe diabetic retinopathy.

Primary outcome measures

  • Change in Knowledge Concordance Assessed through Validated Questionarres [Time frame: 12 months]
Secondary outcome measures (2)
  • Follow Up Adherence, Assessed through Electronic Record Review [Time frame: 12 months]
  • Diabetic Retinopathy Progression, Assessed through Electronic Health Record Review [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • Diagnosis of diabetes mellitus with or without diabetic retinopathy
  • Scheduled visit to ZSFG clinic is specifically for diabetes mellitus or diabetic retinopathy care
  • Able to speak and understand English or Spanish

Exclusion criteria

  • Unable to view or understand the videos due to significant vision obstruction or impairment

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Zuckerberg San Francisco General Hospital and Trauma Center — San Francisco

Identifiers

NCT: NCT07519707 · 24-43161

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗